Natural Alternatives International, Inc. (NAI), San Marcos, CA, a formulator, manufacturer and marketer of customized nutritional supplements, was issued U.S. Patent No. RE45,947 entitled “Methods and compositions for increasing the anaerobic working capacity in tissues” by the  U.S. Patent and Trademark Office.
 
The newly reissued patent becomes part of NAI’s global patent estate covering its CarnoSyn beta-alanine product.
 
Mark A. LeDoux, NAI’s CEO and chairman of the board, said, “This new patent is yet another example of NAI’s ongoing commitment to the growth and protection of its CarnoSyn beta-alanine patent portfolio. We will continue to pursue opportunities to expand our CarnoSyn business around the world through vigorous research, development and enforcement of intellectual property.”
 
NAI’s new patent contains claims directed to beta-alanine compositions, wherein the beta-alanine is not part of a dipeptide, polypeptide or oligopeptide and is in the form of a dietary supplement, with additional active agents, such as carbohydrates and creatine.